| SEQ_NO | 1 | Date of announcement | 2025/05/14 | Time of announcement | 23:38:35 |
| Subject | Medeon received the Milestone Abandonment Notice from Terumo | ||||
| Date of events | 2025/05/14 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2025/05/14 2.Company name:Medeon Biodesign, Inc. 3.Relationship to the Company (please enter ‘head office’ or ‘subsidiaries’):head office 4.Reciprocal shareholding ratios:NA 5.Cause of occurrence: On May 14, 2025, Taipei time, Medeon was notified by Terumo Medical Corporation (hereinafter referred to as Terumo) that in light of the pandemic and supply chain challenges, the timeline for launching Cross-Seal (Large-bore Closure Device) was revised, and has the potential impact on its original objectives. In accordance of the Cross-Seal Asset Purchase Agreement and Master Services Agreement, Terumo proceeded to formally submit the Milestone Abandonment Notice to Medeon. Cross-Seal Asset Purchase Agreement is still effective. Both parties |
||||